Home › Trial NCT00975182
A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors
- Trial IDNCT00975182
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorGenentech, Inc.
- Enrollment58
- Start date2009-09
- ConditionsNon-Squamous Non-Small Cell Lung Cancer, Solid Cancers
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.